Moustapha Hassan

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Moustapha Hassan utnämndes till professor i transplantationsforskning vid institutionen för laboratoriemedicin 2013. Hans forskning handlar om förbättrad överlevnad och livskvalitet hos cancerpatienter som behandlas med cytostatika och stamcellstransplantation.

Artiklar

Article: NEOPLASIA. 2025;65:101165
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer
Wu Y; Wang G; Yang R; Zhou D; Chen Q; Wu Q; Chen B; Yuan L; Qu N; Wang H; Hassan M; Zhao Y; Liu M; Shen Z; Zhou W
Article: BONE MARROW TRANSPLANTATION. 2025
Mechanisms underlying seizures and hypothermia during busulphan administration.
El-Serafi I; Berglund S; BenKessou F; Codita A; Saghafian M; Lindskog D; Dorst MC; Silberberg G; Abedi-Valugerdi M; Zheng W; He R; Renault M; Zhou W; Yu C; Vosough M; Oerther S; Zhao Y; Mattsson J; Hassan M
Article: ADVANCED FUNCTIONAL MATERIALS. 2025;35(1)
Exploring the Intracellular Distribution of Se Compounds Delivered by Biodegradable Polyelectrolyte Capsules Using X-Ray Fluorescence Imaging
Skiba M; Reszegi RR; Huang Y; Roy S; Han J; Brueckner D; Sanchez-Cano C; Zhao Y; Hassan M; Feliu N; Falkenberg G; Parak WJ
Article: CELL JOURNAL. 2024;26(8):505-514
Application of XBP1s Decoy Oligodeoxynucleotide Attenuates Cancerous Phenotype in Huh-7 Hepatocellular Carcinoma Cells
Bahadori S; Farzaneh Z; Solhi R; Hajilou Z; Shokouhian B; Hassan M; Najimi M; Vosough M
Article: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2024;203:114470
MiR-29a-laden extracellular vesicles efficiently induced apoptosis through autophagy blockage in HCC cells
Seydi H; Nouri K; Shokouhian B; Piryaei A; Hassan M; Cordani M; Zarrabi A; Shekari F; Vosough M
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2024;28(18):e18507
Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles induce liver fibrosis-resolving phenotype in alternatively activated macrophages
Torabi S; Zarrabi M; Shekari F; Poorkazem H; Lotfinia M; Bencina S; Gramignoli R; Hassan M; Najimi M; Vosough M
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2024;129:111584
Tumor cell derived osteopontin and prostaglandin E2 synergistically promote the expansion of myeloid derived suppressor cells during the tumor immune escape phase
Mamand DR; Bazaz S; Mohammad DK; Saher O; Wiklander OPB; Sadeghi B; Hassan M; EL-Andaloussi S; Abedi-Valugerdi M
Article: HELIYON. 2024;10(2):e24948
Immunomodulatory performance of GMP-compliant, clinical-grade mesenchymal stromal cells from four different sources
Arki MK; Moeinabadi-Bidgoli K; Niknam B; Mohammadi P; Hassan M; Hossein-Khannazer N; Vosough M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(9):581.e1-581.e8
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation
Carreira AS; Salas MQ; Remberger M; Novitzky-Basso I; Law AD; Lam W; Pasic I; Mazzulli T; Cserti-Gazdewich C; Kim DDH; Michelis FV; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Hassan M; Mattsson J
Article: CELL JOURNAL. 2023;25(8):524-535
Umbilical Cord Blood-Derived Monocytes as A Reliable Source of Functional Macrophages for Biomedical Research
Torabi S; Zarrabi M; Hossein-Khannazer N; Lotfinia M; Nouri M; Gramignoli R; Hassan M; Vosough M
Article: NANO TODAY. 2023;50:101824
NIR light-driven photocatalytic NAD(P)H oxidation and H2O2 generation in situ for enhanced chemodynamic therapy and immune response
Zhang C; Huang J; Guo X; Da X; Dai Z; Hassan M; Yu Y; Wang X; Zhou Q
Article: PHYTOMEDICINE. 2023;110:154634
Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus
Zhou D; Li X; Xiao X; Wang G; Chen B; Song Y; Liu X; He Q; Zhang H; Wu Q; Zhang L; Wu L; Shen Z; Hassan M; Zhao Y; Zhou W
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023;11(2):e005691
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
Schoutrop E; Poiret T; El-Serafi I; Zhao Y; He R; Moter A; Henriksson J; Hassan M; Magalhaes I; Mattsson J
Article: MOLECULAR AND CELLULAR BIOCHEMISTRY. 2023;478(1):23-37
Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
Mahsa P; Asadian S; Mirzaei H; Minaei A; Shahriari E; Shpichka A; Es HA; Timashev P; Hassan M; Vosough M
Article: JOURNAL OF BIOMEDICAL NANOTECHNOLOGY. 2023;19(1):28-35
Perfluorocarbon-Encapsulated Porphyrin-Lipid Nanoparticles as a Photoactive Pyroptosis Inducer for Cancer Therapy
Lin X; Jiang X; Xu Y; Liu R; Zhang N; Li R; Xiang H; Zhao C; Zhao Z; Zeng W; Qu S; Tan X; Cheng C; Chen X; Wang M; Liu Y; Liu L; Zhao Y; Dai Z; Hassan M; Sun D
Article: STEM CELLS INTERNATIONAL. 2022;2022:1850305-14
Conjugated Linoleic Acid Treatment Attenuates Cancerous features in Hepatocellular Carcinoma Cells
Miri-Lavasani Z; Torabi S; Solhi R; Shokouhian B; Afsharian P; Heydari Z; Piryaei A; Farzaneh Z; Hossein-khannazer N; Es HA; Zahmatkesh E; Nussler A; Hassan M; Najimi M; Vosough M
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2022;106:108587
Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages
Ebrahimiyan H; Tamimi A; Shokoohian B; Minaei N; Memarnejadian A; Hossein-Khannazer N; Hassan M; Vosough M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2022;28(4):196-202
Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation
Bognar T; Bartelink IH; Egberts TCG; Rademaker CMA; Versluys AB; Slatter MA; Kletzel M; Nath CE; Cuvelier GDE; Savic RM; Dvorak C; Long-Boyle JR; Cowan MJ; Bittencourt H; Bredius RGM; Gungor T; Shaw PJ; Ansari M; Hassan M; Krajinovic M; Hempel G; Marktel S; Chiesa R; Theoret Y; Lund T; Orchard PJ; Wynn RF; Boelens JJ; Lalmohamed A
Article: BMJ GLOBAL HEALTH. 2022;7(4):e008143
Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countries
Rees CA; Colbourn T; Hooli S; King C; Lufesi N; McCollum ED; Mwansambo C; Cutland C; Madhi SA; Nunes M; Matthew JL; Addo-Yobo E; Chisaka N; Hassan M; Hibberd PL; Jeena PM; Lozano JM; MacLeod WB; Patel A; Thea DM; Nguyen NTV; Kartasasmita CB; Lucero M; Awasthi S; Bavdekar A; Chou M; Nymadawa P; Pape J-W; Paranhos-Baccala G; Picot VS; Rakoto-Andrianarivelo M; Rouzier V; Russomando G; Sylla M; Vanhems P; Wang J; Asghar R; Banajeh S; Iqbal I; Maulen-Radovan I; Mino-Leon G; Saha SK; Santosham M; Singhi S; Basnet S; Strand TA; Bhatnagar S; Wadhwa N; Lodha R; Aneja S; Clara AW; Campbell H; Nair H; Falconer J; Qazi SA; Nisar YB; Neuman MI
Article: CELLS. 2022;11(2):305
Rhenium Perrhenate (¹⁸⁸ReO₄) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells
Asadian S; Piryaei A; Gheibi N; Kalantari BA; Davarpanah MR; Azad M; Kapustina V; Alikhani M; Nejad SM; Alikhani HK; Mohamadi M; Shpichka A; Timashev P; Hassan M; Vosough M
Article: NPJ BREAST CANCER. 2022;8(1):2
Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancer
Li X; Zhou D; Cai Y; Yu X; Zheng X; Chen B; Li W; Zeng H; Hassan M; Zhao Y; Zhou W
Article: JOURNAL OF PERSONALIZED MEDICINE. 2022;12(1):42
COL-3-Induced Molecular and Ultrastructural Alterations in K562 Cells
Fares M; Oerther S; Hultenby K; Gubrianska D; Zhao Y; Abedi-Valugerdi M; Hassan M
Article: CANCER RESEARCH. 2021;81(11):3022-3035
Mesothelin-Specific CAR T Cells Target Ovarian Cancer
Schoutrop E; El-Serafi I; Poiret T; Zhao Y; Gultekin O; He R; Moyano-Galceran L; Carlson JW; Lehti K; Hassan M; Magalhaes I; Mattsson J
Article: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2021;601:120588
Biodistribution of fluorescence-labelled EGF protein from slow release NanoZolid depots in mouse
Gruden S; Brunmark C; Holmqvist B; Brenndorfer ED; Johansson M; Liu J; Zhao Y; Axen N; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2021;56(4):807-817
Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study
El-Serafi A; He R; Zheng W; Benkossou F; Oerther S; Zhao Y; Mellgren K; Gustafsson B; Heilmann C; Kanerva J; Lotfi K; Toporski J; Sundin M; Hoglund M; Mattsson J; El-Serafi I; Hassan M
Article: SCIENTIFIC REPORTS. 2021;11(1):2707
Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study
Gernaat SAM; von Stedingk H; Hassan M; Nilsson HP; Rodriguez-Wallberg KA; Hedayati E; Rydberg P
Article: ACS APPLIED MATERIALS & INTERFACES. 2020;12(48):53665-53681
Multimodal Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional Nanoparticles as Contrast Agents
Zhao Y; Ye F; Brismar TB; Li X; He R; Heuchel R; El-Sayed R; Feliu N; Zheng W; Oerther S; Dutta J; Parak WJ; Muhammed M; Hassan M
Article: PHARMACOLOGICAL RESEARCH. 2020;160:105070
β-radiating radionuclides in cancer treatment, novel insight into promising approach
Asadian S; Mirzaei H; Kalantari BA; Davarpanah MR; Mohamadi M; Shpichka A; Nasehi L; Es HA; Timashev P; Najimi M; Gheibi N; Hassan M; Vosough M
Article: BLOOD ADVANCES. 2020;4(9):1998-2010
Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis
Felber M; Steward CG; Kentouche K; Fasth A; Wynn RF; Zeilhofer U; Haunerdinger V; Volkmer B; Prader S; Gruhn B; Ehl S; Lehmberg K; Mueller D; Gennery AR; Albert MH; Hauck F; Rao K; Veys P; Hassan M; Lankester AC; Schmid JP; Hauri-Hohl MM; Guengoer T
Article: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2020;143:105158
Pharmacokinetic profile of N-acetylcysteine amide and its main metabolite in mice using new analytical method
He R; Zheng W; Ginman T; Ottosson H; Norgren S; Zhao Y; Hassan M
Article: SCIENTIFIC REPORTS. 2020;10(1):1274
A general covalent binding model between cytotoxic selenocompounds and albumin revealed by mass spectrometry and X-ray absorption spectroscopy
Zheng W; He R; Boada R; Subirana MA; Ginman T; Ottosson H; Valiente M; Zhao Y; Hassan M
Article: FRONTIERS IN PHARMACOLOGY. 2020;11:406
Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients
Ahmed JH; Makonnen E; Bisaso RK; Mukonzo JK; Fotoohi A; Aseffa A; Howe R; Hassan M; Aklillu E
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2020;78:106042
The kidney injury caused by the onset of acute graft-versus-host disease is associated with down-regulation of αKlotho
Amin R; He R; Gupta D; Zheng W; Burmakin M; Mohammad DK; DePierre JW; Sadeghi B; Olauson H; Wernerson A; El-Andaloussi S; Hassan M; Abedi-Valugerdi M
Article: CLINICAL TRANSPLANTATION. 2019;33(12):e13742
Bone and hormonal status 10 years post-allogeneic bone marrow transplantation
Gubrianska D; Machaczka M; Hassan M; Hagglund H; Ljungman P; Palmer M
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2019;20(19):E4734-4734
Extracellular Albumin Covalently Sequesters Selenocompounds and Determines Cytotoxicity
Zheng W; Boada R; He R; Xiao T; Ye F; Simonelli L; Valiente M; Zhao Y; Hassan M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(9):1890-1897
Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement
McCune JS; Quinones CM; Ritchie J; Carpenter PA; van Maarseveen E; Yeh RF; Anasetti C; Boelens JJ; Hamerschlak N; Hassan M; Kang HJ; Kanda Y; Paci A; Perales M-A; Shaw PJ; Seewaldt VL; Savani BN; Hsieh A; Poon B; Mohty M; Pulsipher MA; Pasquini M; Dupuis LL
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2019;515(3):487-492
Degradation of pristine and oxidized single wall carbon nanotubes by CYP3A4
El-Sayed R; Waraky A; Ezzat K; Albabtain R; Eigammal K; Shityakov S; Muhammed M; Hassan M
Article: BEHAVIOURAL BRAIN RESEARCH. 2019;367:28-34
Sustained overexpression of neuropeptide S in the amygdala reduces anxiety-like behavior in rats
Tillmann S; Skibdal HE; Christiansen SH; Gotzsche CR; Hassan M; Mathe AA; Wegener G; Woldbye DPD
Article: APPLIED MATERIALS TODAY. 2019;15:267-279
Tracking stem cells and macrophages with gold and iron oxide nanoparticles - The choice of the best suited particles
Sun X; Gamal M; Nold P; Said A; Chakraborty I; Pelaz B; Schmied F; von Pueckler K; Figiel J; Zhao Y; Brendel C; Hassan M; Parak WJ; Feliu N
Article: SCIENTIFIC REPORTS. 2019;9(1):3903
CT Scanning and MATLAB Calculations for Preservation of Coptic Mural Paintings in Historic Egyptian Monasteries
Sallam A; Hemeda S; Toprak MS; Muhammed M; Hassan M; Uheida A
Article: FRONTIERS IN PHARMACOLOGY. 2019;10:481
CYP2J2*7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients
Ahmed JH; Makonnen E; Yimer G; Seifu D; Bekele A; Assefa M; Aseffa A; Howes R; Fotoohi A; Hassan M; Aklillu E
Article: BEHAVIOURAL BRAIN RESEARCH. 2018;351:93-103
Sex-dependent behavior, neuropeptide profile and antidepressant response in rat model of depression
Sanchez C; El Khoury A; Hassan M; Wegener G; Mathe AA
Article: ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. 2018;19(8):2305-2311
miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines.
Ostadrahimi S; Abedi Valugerdi M; Hassan M; Haddad G; Fayaz S; Parvizhamidi M; Mahdian R; Fard Esfahani P
Article: JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY. 2018;46:482-489
Cold isostatic pressing of hydrating calcium sulfate as a means to produce parenteral slow-release drug formulations
Gruden S; Hassan M; Axen N
Article: SCIENTIFIC REPORTS. 2018;8(1):8293
The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation
El-Serafi I; Remberger M; El-Serafi A; Benkessou F; Zheng W; Martell E; Ljungman P; Mattsson J; Hassan M
Article: ONCOLOGY LETTERS. 2018;15(5):8157-8164
Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines
Ostadrahimi S; Fayaz S; Parvizhamidi M; Abedi-Valugerdi M; Hassan M; Kadivar M; Teimoori-Toolabi L; Asgari M; Shahrokh H; Abolhasani M; Mandian R; Fard-Esfahani P
Article: JOURNAL OF THEORETICAL BIOLOGY. 2018;442:1-10
Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies
Shariatpanahi SP; Shariatpanahi SP; Madjidzadeh K; Hassan M; Abedi-Valugerdi M
Article: NANO TODAY. 2018;18:103-123
Advances in nanotechnology for cancer biomarkers
Ye F; Zhao Y; Ei-Sayed R; Muhammed M; Hassan M
Article: JOURNAL OF CLINICAL APHERESIS. 2017;32(6):384-391
G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield
Machaczka M; Hagglund H; Staver E; Joks M; Hassan M; Wahlin BE; Nygell UA
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
Remberger M; Torlen J; El Serafi I; Garming-Legert K; Bjorklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2017;491(1):15-18
Importance of the surface chemistry of nanoparticles on peroxidase-like activity
El-Sayed R; Ye F; Asem H; Ashour R; Zheng W; Muhammed M; Hassan M
Article: EXPERIMENTAL HEMATOLOGY. 2017;52:65-71
Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions
Valdez BC; Hassan M; Andersson BS
Article: ANALYTICAL CHEMISTRY. 2017;89(14):7586-7592
Rapid and Robust Quantification of p-Xyleneselenocyanate in Plasma via Derivatization
Zheng W; Benkessou F; Twelkmeyer B; Wang S; Ginman T; Ottosson H; Abedi-Valugerdi M; Angels Subirana M; Zhao Y; Hassan M
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2017;47:173-181
Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice
Abedi-Valugerdi M; Zheng W; Benkessou F; Zhao Y; Hassan M
Article: PLOS ONE. 2017;12(11):e0187294
Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
El-Serafi I; Terelius Y; Abedi-Valugerdi M; Naughton S; Saghafian M; Moshfegh A; Mattsson J; Potacova Z; Hassan M
Article: JOURNAL OF NANOBIOTECHNOLOGY. 2016;14(1):82
Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging
Asem H; Zhao Y; Ye F; Barrefelt A; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(11):1915-1925
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
Palmer J; McCune JS; Perales M-A; Marks D; Bubalo J; Mohty M; Wingard JR; Paci A; Hassan M; Bredeson C; Pidala J; Shah N; Shaughnessy P; Majhail N; Schriber J; Savani BN; Carpenter PA
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2016;40:41-49
Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice
Abedi-Valugerdi M; Wolfsberger J; Pillai PR; Zheng W; Sadeghi B; Zhao Y; Hassan M
Article: LANCET HAEMATOLOGY. 2016;3(11):e526-e536
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis
Bartelink IH; Lalmohamed A; van Reij EML; Dvorak CC; Savic RM; Zwaveling J; Bredius RGM; Egberts ACG; Bierings M; Kletzel M; Shaw PJ; Nath CE; Hempel G; Ansari M; Krajinovic M; Theoret Y; Duval M; Keizer RJ; Bittencourt H; Hassan M; Gungor T; Wynn RF; Veys P; Cuvelier GDE; Marktel S; Chiesa R; Cowan MJ; Slatter MA; Stricherz MK; Jennissen C; Long-Boyle JR; Boelens JJ
Article: PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY. 2016;13:48-57
Development and biodistribution of a theranostic aluminum phthalocyanine nanophotosensitizer
Asem H; Abd El-Fattah A; Nafee N; Zhao Y; Khalil L; Muhammed M; Hassan M; Kandil S
Article: PHARMACOGENOMICS JOURNAL. 2015;15(5):405-413
Cytochrome P450 2J2, a new key enzyme in cyclophosphamide bioactivation and a potential biomarker for hematological malignancies
El-Serafi I; Fares M; Abedi-Valugerdi M; Afsharian P; Moshfegh A; Terelius Y; Potacova Z; Hassan M
Article: CELL METABOLISM. 2015;22(3):408-417
Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis
Ryden M; Uzunel M; Hard JL; Borgstrom E; Mold JE; Arner E; Mejhert N; Andersson DP; Widlund Y; Hassan M; Jones CV; Spalding KL; Svahn B-M; Ahmadian A; Frisen J; Bernard S; Mattsson J; Arner P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2015;464(3):737-742
Fluorescence labeled microbubbles for multimodal imaging
Barrefelt A; Zhao Y; Larsson MK; Egri G; Kuiper RV; Hamm J; Saghafian M; Caidahl K; Brismar TB; Aspelin P; Heuchel R; Muhammed M; Dahne L; Hassan M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2015;463(3):268-274
DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell line
Fares M; Abedi-Valugerdi M; Hassan M; Potacova Z
Article: CHEMOSPHERE. 2015;129:225-231
Complement activation is involved in the hepatic injury caused by high-dose exposure of mice to perfluorooctanoic acid
Botelho SC; Saghafian M; Pavlova S; Hassan M; DePierre JW; Abedi-Valugerdi M
Article: CHRONOBIOLOGY INTERNATIONAL. 2015;32(5):608-614
The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model
Sallam H; El-Serafi AT; Filipski E; Terelius Y; Levi F; Hassan M
Article: IMMUNOLOGY LETTERS. 2015;163(2):193-198
Immunotoxicological effects of streptozotocin and alloxan: In vitro and in vivo studies
Diab RAH; Fares M; Abedi-Valugerdi M; Kumagai-Braesch M; Holgersson J; Hassan M
Article: PLOS ONE. 2015;10(11):e0141979
Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
El-Serafi I; Afsharian P; Moshfegh A; Hassan M; Terelius Y
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(8):4941-4943
Posaconazole Concentrations in Human Tissues after Allogeneic Stem Cell Transplantation
Blennow O; Eliasson E; Pettersson T; Pohanka A; Szakos A; El-Serafi I; Hassan M; Ringden O; Mattsson J
Article: NANO. 2014;9(6):1450069
DYNAMIC MR IMAGING, BIODISTRIBUTION AND PHARMACOKINETICS OF POLYMER SHELLED MICROBUBBLES CONTAINING SPION
Barrefelt A; Paradossi G; Asem H; Margheritelli S; Saghafian M; Oddo L; Muhammed M; Aspelin P; Hassan M; Brismar TB
Article: LEUKEMIA & LYMPHOMA. 2014;55(7):1618-1624
The nanoparticulate Quillaja saponin KGI exerts anti-proliferative eff ects by down-regulation of cell cycle molecules in U937 and HL-60 human leukemia cells
Berenjian S; Hu K; Abedi-Valugerdi M; Hassan M; Hassan SB; Morein B
Article: XENOTRANSPLANTATION. 2014;21(4):353-366
Rat islets are not rejected by anti-islet antibodies in mice treated with costimulation blockade
Diab RAH; Hassan M; Tibell A; Holgersson J; Kumagai-Braesch M
Article: BIOMATERIALS. 2014;35(12):3885-3894
Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging
Ye F; Barrefelt A; Asem H; Abedi-Valugerdi M; El-Serafi I; Saghafian M; Abu-Salah K; Alrokayan S; Muhammed M; Hassan M
Article: LANCET. 2014;383(9915):436-448
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study
Guengoer T; Teira P; Slatter M; Stuessi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M
Article: CLINICAL DRUG INVESTIGATION. 2014;34(1):43-52
Comparison of Algorithms for Oral Busulphan Area Under the Concentration-Time Curve Limited Sampling Estimate
Sjoo F; El-Serafi I; Enestig J; Mattsson J; Liwing J; Hassan M
Article: THERANOSTICS. 2014;4(6):604-613
Real-Time Assessment of Tissue Hypoxia In Vivo with Combined Photoacoustics and High-Frequency Ultrasound
Gerling M; Zhao Y; Nania S; Norberg KJ; Verbeke CS; Englert B; Kuiper RV; Bergstrom A; Hassan M; Neesse A; Lohr JM; Heuchel RL
Article: PLOS ONE. 2014;9(1):e86619
Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation
El-Serafi I; Abedi-Valugerdi M; Potacova Z; Afsharian P; Mattsson J; Moshfegh A; Hassan M
Article: BMC PHARMACOLOGY & TOXICOLOGY. 2013;14:50
Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor-CR8-in mice
Sallam H; El-Serafi I; Meijer L; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2013;48(6):843-848
Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion
Al Hashmi S; Sadeghi B; Hassan Z; Abedi-Valugerdi M; Lindskog M; Hassan M
Article: TOXICOLOGY LETTERS. 2013;219(1):1-7
Sub-acute, moderate-dose, but not short-term, low-dose dietary pre-exposure of mice to perfluorooctanoate aggravates concanavalin A-induced hepatitis
Qazi MR; Hassan M; Nelson BD; DePierre JW; Abedi-Valugerdi M
Article: PEDIATRIC TRANSPLANTATION. 2013;17(3):285-293
Increased risk of gastrointestinal acute GVHD following the addition of melphalan to busulfan/cyclophosphamide conditioning
Martensson T; Priftakis P; Casswall T; Ringden O; Mattsson J; Remberger M; Hassan M; Gustafsson B
Article: NANO LETTERS. 2013;13(4):1393-1398
Thermostable Luciferase from Luciola cruciate for Imaging of Carbon Nanotubes and Carbon Nanotubes Carrying Doxorubicin Using in Vivo Imaging System
El-Sayed R; Eita M; Barrefelt A; Ye F; Jain H; Fares M; Lundin A; Crona M; Abu-Salah K; Muhammed M; Hassan M
Article: EJNMMI RESEARCH. 2013;3(1):12
Multimodality imaging using SPECT/CT and MRI and ligand functionalized ^99mTc-labeled magnetic microbubbles
Barrefelt AA; Brismar TB; Egri G; Aspelin P; Olsson A; Oddo L; Margheritelli S; Caidahl K; Paradossi G; Daehne L; Axelsson R; Hassan M
Article: TOXICOLOGY LETTERS. 2013;217(1):67-74
Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis
Qazi MR; Hassan M; Nelson BD; DePierre JW; Abedi-Valugerdi M
Article: BONE MARROW TRANSPLANTATION. 2013;48(2):284-293
Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?
Sadeghi B; Al-Chaqmaqchi H; Al-Hashmi S; Brodin D; Hassan Z; Abedi-Valugerdi M; Moshfegh A; Hassan M
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2013;913:98-105
Gas chromatographic-mass spectrometry method for the detection of busulphan and its metabolites in plasma and urine
El-Serafi I; Terelius Y; Twelkmeyer B; Hagbjork A-L; Hassan Z; Hassan M
Article: PLOS ONE. 2013;8(7):e68937
Activation of Wnt/β-Catenin Pathway in Monocytes Derived from Chronic Kidney Disease Patients
Al-Chaqmaqchi HAM; Moshfegh A; Dadfar E; Paulsson J; Hassan M; Jacobson SH; Lundahl J
Article: INTERNATIONAL JOURNAL OF NANOMEDICINE. 2013;8:3241-3254
Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat
Barrefelt A; Saghafian M; Kuiper R; Ye F; Egri G; Klickermann M; Brismar TB; Aspelin P; Muhammed M; Daehne L; Hassan M
Article: PLOS ONE. 2013;8(4):e60367
The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease
Al-Chaqmaqchi H; Sadeghi B; Abedi-Valugerdi M; Al-Hashmi S; Fares M; Kuiper R; Lundahl J; Hassan M; Moshfegh A
Article: PLOS ONE. 2012;7(1):e30897
Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase
Al-Hashmi S; Boels PJM; Zadjali F; Sadeghi B; Sallstrom J; Hultenby K; Hassan Z; Arner A; Hassan M
Article: NATURE MEDICINE. 2011;17(12):1636-1640
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
D'Arcy P; Brnjic S; Olofsson MH; Fryknäs M; Lindsten K; De Cesare M; Perego P; Sadeghi B; Hassan M; Larsson R; Linder S
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: ORAL DISEASES. 2011;17(7):670-676
Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI
Garming-Legert K; Remberger M; Ringden O; Hassan M; Dahllof G
Article: PEDIATRIC TRANSPLANTATION. 2011;15(6):580-588
Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipients
Malaer R; Sjoo F; Rentsch K; Hassan M; Guengoer T
Article: INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 2011;4(6):596-605
Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen
Al-Hashmi S; Hassan Z; Sadeghi B; Rozell B; Hassan M
Article: SULTAN QABOOS UNIVERSITY MEDICAL JOURNAL. 2011;11(2):165-178
The Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - Roscovitine.
Hassan M; Sallam H; Hassan Z
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2011;41(4):1143-1153
N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitro
Karlsson H; Nava S; Remberger M; Hassan Z; Hassan M; Ringden O
Article: CLINICAL AND DEVELOPMENTAL IMMUNOLOGY. 2010;2010:142943
Expansion and Activation Kinetics of Immune Cells during Early Phase of GVHD in Mouse Model Based on Chemotherapy Conditioning
Sadeghi B; Al-Hashmi S; Hassan Z; Rozell B; Concha H; Lundmark C; Gronvik K-O; Abedi-Valugerdi M; Hassan M
Article: CHRONOBIOLOGY INTERNATIONAL. 2009;26(8):1613-1621
CIRCADIAN VARIABILITY OF BILIRUBIN IN HEALTHY MEN DURING NORMAL SLEEP AND AFTER AN ACUTE SHIFT OF SLEEP
Larsson A; Hassan M; Ridefelt P; Axelsson J
Article: CHRONOBIOLOGY INTERNATIONAL. 2009;26(6):1169-1188
Liver Circadian Clock, a Pharmacologic Target of Cyclin-Dependent Kinase Inhibitor Seliciclib
Iurisci I; Filipski E; Sallam H; Harper F; Guettier C; Maire I; Hassan M; Iacobelli S; Levi F
Article: BONE MARROW TRANSPLANTATION. 2008;42(12):807-818
GVHD after chemotherapy conditioning in allogeneic transplanted mice
Sadeghi B; Aghdami N; Hassan Z; Forouzanfar M; Rozell B; Abedi-Valugerdi M; Hassan M
Article: MOLECULAR CANCER THERAPEUTICS. 2008;7(9):2713-2724
N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine
Bettayeb K; Sallam H; Ferandin Y; Popowycz F; Fournet G; Hassan M; Echalier A; Bernard P; Endicott J; Joseph B; Meijer L
Article: TRANSPLANTATION. 2008;86(2):257-263
Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation
Avetisyan G; Aschan J; Hassan M; Ljungman P
Article: PHARMACOLOGICAL RESEARCH. 2008;58(1):32-37
Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain
Sallam H; Jimenez P; Song H; Vita M; Cedazo-Minguez A; Hassan M
Article: NATURE. 2008;453(7196):783-787
Dynamics of fat cell turnover in humans
Spalding KL; Arner E; Westermark PO; Bernard S; Buchholz BA; Bergmann O; Blomqvist L; Hoffstedt J; Naslund E; Britton T; Concha H; Hassan M; Ryden M; Frisen J; Arner P
Article: BONE MARROW TRANSPLANTATION. 2008;41(9):785-790
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation
Barkholt L; Remberger M; Hassan Z; Fransson K; Omazic B; Svahn B-M; Karlsson H; Brune M; Hassan M; Mattsson J; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2008;41(10):895-904
The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model
Sadeghi B; Jansson M; Hassan Z; Mints M; Hagglund H; Abedi-Valugerdi M; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2008;41(7):621-625
Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population:: A comparative study between the standard 4-dose and a 2-dose regimen
Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Winiarski J; Ringden O; Hassan M
Article: JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES. 2008;31(5):683-694
Rapid and sensitive method for determination of cyclophosphamide in patients plasma samples utilizing microextraction by packed sorbent online with liquid chromatography-tandem mass spectrometry (MEPS-LC-MS/MS)
Said R; Hassan Z; Hassan M; Abdel-Rehim M
Article: EXPERIMENTAL HEMATOLOGY. 2008;36(2):149-157
Hypomethylation and apoptosis in 5-azacytidine-treated myeloid cells
Khan R; Schmidt-Mende J; Karim M; Gogvadze V; Hassan M; Ekstrom TJ; Zhivotovsky B; Hellstrom-Lindberg E
Article: HUMAN REPRODUCTION. 2008;23(1):139-143
Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient
Mints M; Jansson M; Sadeghi B; Westgren M; Uzunel M; Hassan M; Palmblad J
Article: JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES. 2007;30(20):3029-3041
Simultaneous determination of busulphan in plasma samples by liquid chromatography-electrospray ionization mass spectrometry utilizing microextraction in packed syringe (MEPS) as on-line sample preparation method
Abdel-Rehim M; Hassan Z; Skansem P; Hassan M
Article: THERAPEUTIC DRUG MONITORING. 2007;29(5):626-631
Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia
Lofgren C; Lehmann S; Jonsson-Videsater K; Mollgard L; Linder O; Tidefelt U; Hassan M; Paul C
Article: CLINICAL CANCER RESEARCH. 2007;13(14):4218-4224
The effect of repeated administration of cyclophosphamide on cytochrome P4502B in rats
Afsharian P; Zuzana YT; Hassan Z; Nilsson C; Lundgren S; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2006;38(10):687-692
Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation
Avetisyan G; Larsson K; Aschan J; Nilsson C; Hassan M; Ljungman P
Article: NATURE MEDICINE. 2006;12(4):401-409
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
Ott MG; Schmidt M; Schwarzwaelder K; Stein S; Siler U; Koehl U; Glimm H; Kühlcke K; Schilz A; Kunkel H; Naundorf S; Brinkmann A; Deichmann A; Fischer M; Ball C; Pilz I; Dunbar C; Du Y; Jenkins NA; Copeland NG; Lüthi U; Hassan M; Thrasher AJ; Hoelzer D; von Kalle C; Seger R; Grez M
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2006;98(2):197-200
Inhibitory effect of 5-fluorouracil on cytochrome P4502C9 activity in cancer patients
Gunes A; Coskun U; Boruban C; Gunel N; Babaoglu MO; Sencan O; Bozkurt A; Rane A; Hassan M; Zengil H; Yasar U
Article: EXPERIMENTAL HEMATOLOGY. 2006;34(1):115-121
Myeloablative and immunosuppressive properties of treosulfan in mice
Sjöö F; Hassan Z; Abedi-Valugerdi M; Griskevicius L; Nilsson C; Remberger M; Aschan J; Concha H; Gaughan U; Hassan M
Article: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2006;27(1):54-61
Pharmacogenetics of cyclophosphamide in patients with hematological malignancies
Xie HJ; Griskevicius L; Ståhle L; Hassan Z; Yasar Ü; Rane A; Broberg U; Kimby E; Hassan M
Article: EXPERIMENTAL HEMATOLOGY. 2006;34(1):35-43
Pharmacodynamic study of 5-azacytidine in the P39 cell line
Khan R; Aggerholm A; Hokland P; Hassan M; Hellström-Lindberg E
Article: BONE MARROW TRANSPLANTATION. 2005;36(5):411-415
Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients
Avetisyan G; Ragnavölgyi E; Toth GT; Hassan M; Ljungman P
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2005;75(3):206-211
The effect of ciprofloxacin on cyclophosphamide pharmacokinetics in patients with non-Hodgkin lymphoma
Afsharian P; Möllgård L; Hassan Z; Xie HJ; Kimby E; Hassan M
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2005;821(1):75-80
Stability, pKa and plasma protein binding of roscovitine
Vita M; Abdel-Rehim M; Nilsson C; Hassan Z; Skansen P; Wan H; Meurling L; Hassan M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2005;141(2):238-247
Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice
Abedi-Valugerdi M; Nilsson C; Zargari A; Gharibdoost F; DePierre JW; Hassan M
Article: TRANSPLANTATION. 2005;79(11):1607-1614
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta
Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Åström E; Westgren M
Article: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2005;25(1):91-103
Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat
Vita M; Abdel-Rehim M; Olofsson S; Hassan Z; Meurling L; Sidén Å; Sidén M; Pettersson T; Hassan M
Article: ANALYTICA CHIMICA ACTA. 2005;539(1-2):35-39
Microextraction in packed syringe/liquid chromatography/electrospray tandem mass spectrometry for quantification of olomoucine in human plasma samples
Abdel-Rehim M; Skansen P; Vita M; Hassan Z; Blomberg L; Hassan M
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2005;817(2):303-307
Development and validation of a liquid chromatography and tandem mass spectrometry method for determination of roscovitine in plasma and urine samples utilizing on-line sample preparation
Vita M; Skansen P; Hassan M; Abdel-Rehim M
Article: EXPERIMENTAL HEMATOLOGY. 2005;33(3):380-387
Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice
Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
Article: IMMUNOLOGY. 2005;114(3):428-437
Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice
Hansson M; Djerbi M; Rabbani H; Mellstedt H; Gharibdoost F; Hassan M; DePierre JW; Abedi-Valugerdi M
Article: XENOBIOTICA. 2005;35(3):239-251
Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat
Xie H; Afsharian P; Terelius Y; Mirghani RA; Yasar Ü; Hagbjörk AL; Lundgren S; Hu Y; Rane A; Hassan M
Article: TRANSPLANTATION. 2004;78(1):154-157
Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation
Mattson J; Jansson M; Wernerson A; Hassan M
Article: LANCET. 2004;363(9419):1439-1441
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Le Blanc K; Rasmusson I; Sundberg B; Götherström C; Hassan M; Uzunel M; Ringdén O
Article: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2004;34(2):425-431
Analysis of roscovitine using novel high performance liquid chromatography and UV-detection method:: pharmacokinetics of roscovitine in rat
Vita M; Meurling L; Pettersson T; Cruz-Sidén M; Sidén Å; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2003;32(5):477-483
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation
Mattsson J; Uzunel M; Remberger M; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2003;32(4):349-354
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation
Sjöö F; Aschan J; Barkholt L; Hassan Z; Ringdén O; Hassan M
Article: CLINICAL CANCER RESEARCH. 2003;9(7):2447-2456
Immunization of colorectal carcinoma patients with a recombinant Canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colonystimulating factor induced a tumor-specific cellular immune response
Ullenhag GJ; Frödin JE; Mosolits S; Kiaii S; Hassan M; Bonnet MC; Moingeon P; Mellstedt H; Rabbani H
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(2):103-109
Bioactivation of cyclophosphamide:: the role of polymorphic CYP2C enzymes
Griskevicius L; Yasar Ü; Sandberg M; Hidestrand M; Eliasson E; Tybring G; Hassan M; Dahl ML
Article: THERAPEUTIC DRUG MONITORING. 2003;25(3):400-406
On-line derivatization utilizing solid-phase microextraction (SPME) for determination of busulphan in plasma using gas chromatography-mass spectrometry (GC-MS)
Abdel-Rehim M; Hassan Z; Blomberg L; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2003;31(6):429-435
The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation
Nilsson C; Aschan J; Hentschke P; Ringdén O; Ljungman P; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2003;31(3):197-203
Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome P450 genes by ciprofloxacin
Xie HJ; Griskevicius L; Broberg U; Lundgren S; Carlens S; Meurling L; Paul C; Rane A; Hassan M
Article: PHARMACOGENOMICS JOURNAL. 2003;3(1):53-61
Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
Xie HJ; Yasar Ü; Lundgren S; Griskevicius L; Terelius Y; Hassan M; Rane A
Article: BONE MARROW TRANSPLANTATION. 2002;30(12):833-841
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation:: 500 mg/m² as a optimal total dose for conditioning
Hassan M; Nilsson C; Hassan Z; Gungor T; Aschan J; Winiarski J; Hentschke P; Ringdén O; Eber S; Seger R; Ljungman P
Article: EUROPEAN JOURNAL OF PHARMACOLOGY. 2002;449(3):197-205
Effect of cyclophosphamide on gene expression of cytochromes P450 and β-actin in the HL-60 cell line
Xie HJ; Lundgren S; Broberg U; Finnström N; Rane A; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2002;30(3):141-147
The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo
Hassan Z; Hellström-Lindberg E; Alsadi S; Edgren M; Hägglund H; Hassan M
Article: THERAPEUTIC DRUG MONITORING. 2002;24(3):405-409
Simple method based on fluorescent detection for the determination of 4-hydroxycyclophosphamide in plasma
Griskevicius L; Meurling L; Hassan M
Article: BRITISH JOURNAL OF CANCER. 2001;85(12):2004-2009
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2001;28(7):657-664
Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients
Sandström M; Karlsson MO; Ljungman P; Hassan Z; Jonsson EN; Nilsson C; Ringden O; Öberg G; Bekassy A; Hassan M
Article: LEUKEMIA. 2001;15(8):1240-1247
The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro
Hassan Z; Hassan M; Hellström-Lindberg E
Article: CLINICAL CANCER RESEARCH. 2001;7(5):1163-1170
Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2
Skog ALH; Wadhwa M; Hassan M; Gharizadeh B; Bird C; Ragnhammar P; Thorpe R; Mellstedt H
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):479-485
Pharmacokinetics of liposomal busulphan in man
Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley HR; Hassan M
Article: JOURNAL OF LIPID RESEARCH. 2001;42(1):70-78
Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol:: a stable isotope study
Meaney S; Hassan M; Sakinis A; Lütjohann D; von Bergmann K; Wennmalm Å; Diczfalusy U; Björkhem I
Article: LEUKEMIA. 2000;14(11):1954-1959
A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation
Olavarria E; Hassan M; Eades A; Nilsson C; Timms A; Matthews J; Craddock C; Kanfer E; Apperley J; Goldman J
Article: THERAPEUTIC DRUG MONITORING. 2000;22(4):383-385
Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy
Hassan M; Svensson JO; Nilsson C; Hentschke P; AL-Shurbaji A; Aschan J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2000;25(9):915-924
The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite:: time interval influence on therapeutic efficacy and therapy-related toxicity
Hassan M; Ljungman P; Ringdén O; Hassan Z; Öberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
Article: JOURNAL OF SEPARATION SCIENCE. 2000;23(2):156-157
Capillary gas chromatography of trichlorophenols using ammonia as carrier gas
Abdel-Rehim M; Hassan M
Article: NUCLEAR MEDICINE AND BIOLOGY. 1999;26(8):931-936
Biodistribution of liposomal ¹³¹I-VIP in rat using gamma camera
Refai E; Jonsson C; Andersson M; Jacobsson H; Larsson S; Kogner P; Hassan M
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1999;48(5):669-677
A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients
Hassan M; Svensson USH; Ljungman P; Björkstrand B; Olsson H; Bielenstein M; Abdel-Rehim M; Nilsson C; Johansson M; Karlsson MO
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1999;63(3):163-170
The influence of interferon-α on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite in patients with multiple myeloma
Hassan M; Nilsson C; Olsson H; Lundin J; Österborg A
Article: NUCLEAR MEDICINE AND BIOLOGY. 1999;26(4):413-420
In vivo dynamic distribution of ¹³¹I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera
Hassan M; Eskilsson A; Nilsson C; Jonsson C; Jacobsson H; Refai E; Larsson S; Efendic S
Article: LIFE SCIENCES. 1999;65(2):165-174
In vivo evaluation of the biodistribution of ¹¹C-labeled PD153035 in rats without and with neuroblastoma implants
Fredriksson A; Johnström P; Thorell JO; von Heijne G; Hassan M; Eksborg S; Kogner P; Borgström P; Ingvar M; Stone-Elander S
Article: BONE MARROW TRANSPLANTATION. 1998;22(9):913-918
Liposomal busulphan: bioavailability and effect on bone marrow in mice
Hassan Z; Nilsson C; Hassan M
Article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 1998;42(6):471-478
Pharmacokinetics and distribution of liposomal busulfan in the rat:: a new formulation for intravenous administration
Hassan M; Hassan Z; Nilsson C; Rehim MA; Kumlien S; Elfsson B; Kållberg N
Article: BONE MARROW TRANSPLANTATION. 1997;20(11):909-913
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients
Ljungman P; Hassan M; Bekassy AN; Ringden O; Oberg G
Article: BONE MARROW TRANSPLANTATION. 1996;18(5):843-850
Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders
Hassan M; Fasth A; Gerritsen B; Haraldsson A; Syruckova Z; vandenBerg H; Sandstrom M; Karlsson M; Kumlien S; Vossen J
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 1996;13(2):143-150
Infection-associated hemophagocytic syndrome complicated by infectious lymphoproliferation: A case report
Syruckova Z; Stary J; Sedlacek P; Smisek P; Vavrinec J; Komrska V; Roubalova K; Vandasova J; Sintakova B; Houskova J; Hassan M
Article: JOURNAL OF SEPARATION SCIENCE. 1996;8(2):151-156
Enantiomer separation of underivatized tocainide and related compounds by CGC using ammonia as carrier gas
AbdelRehim M; Karlen A; Zhang L; Kamel M; Hassan M
Article: JOURNAL OF SEPARATION SCIENCE. 1995;18(12):757-759
Effect of ammonia on the response of the electron capture detector (ECD)
AbdelRehim M; Kamel M; Hassan M
Article: EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. 1995;20(3):225-232
KINETICS AND METABOLISM OF 2-CHLORO-2'-DEOXYADENOSINE AND 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE IN THE ISOLATED-PERFUSED RAT-LIVER
ALBERTIONI F; HASSAN M; SILBERRING J; LILIEMARK J
Article: BONE MARROW TRANSPLANTATION. 1995;15(6):869-871
BUSULFAN CONCENTRATION IN RELATION TO PERMANENT ALOPECIA IN RECIPIENTS OF BONE-MARROW TRANSPLANTS
LJUNGMAN P; HASSAN M; BEKASSY AN; RINGDEN O; OBERG G
Article: INTERNATIONAL PSYCHOGERIATRICS. 1995;7(1):75-83
One year on tacrine (THA): clinical and biochemical effects in patients with dementia of the Alzheimer type.
Ahlin A; Junthé T; Hassan M; Nybäck H
Visa fler

Alla övriga publikationer

Review: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2025;765:110306
c-FLIP/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma
Haghir-Sharif-Zamini Y; Khosravi A; Hassan M; Zarrabi A; Vosough M
Review: EXPERT OPINION ON THERAPEUTIC TARGETS. 2025;29(1-2):59-73
Targeting glypican 3 by immunotoxins: the promise of immunotherapy in hepatocellular carcinoma
Rismani E; Hossein-Khannazer N; Hassan M; Shams E; Najimi M; Vosough M
Review: EXPERIMENTAL CELL RESEARCH. 2025;444(2):114391
GPC-3 in hepatocellular carcinoma; A novel biomarker and molecular target
Tehrani HA; Zangi M; Fathi M; Vakili K; Hassan M; Rismani E; Hossein-Khannazer N; Vosough M
Review: CANCER CELL INTERNATIONAL. 2024;24(1):428
Novel biomarkers for monitoring and management of hepatocellular carcinoma
Solhi R; Pourhamzeh M; Zarrabi A; Hassan M; Mirzaei H; Vosough M
Review: BONE MARROW TRANSPLANTATION. 2024;59(12):1641-1653
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
Domingos V; Nezvalova-Henriksen K; Dadkhah A; Moreno-Martinez M-E; Ben Hassine K; Pires V; Kroeger N; Bauters T; Hassan M; Duncan N; Kalwak K; Ansari M; Langebrake C; Admiraal R
Corrigendum: CELLS. 2024;13(17):1456
Rhenium Perrhenate (¹⁸⁸ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells (vol 11, 305, 2022)
Asadian S; Piryaei A; Gheibi N; Kalantari BA; Davarpanah MR; Azad M; Kapustina V; Alikhani M; Nejad SM; Alikhani HK; Mohamadi M; Shpichka A; Timashev P; Hassan M; Vosough M
Review: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2024;59(5):623-629
Bioengineering vascularized liver tissue for biomedical research and application
Davoodi P; Rezaei N; Hassan M; Hay DC; Vosough M
Review: DRUG DEVELOPMENT RESEARCH. 2024;85(3):e22189
Chitosan-coated nanoparticles in innovative cancer bio-medicine
Rezaei N; Zarkesh I; Fotouhi A; Alikhani HK; Hassan M; Vosough M
Review: CELL JOURNAL. 2024;26(2):98-111
Review on Kidney-Liver Crosstalk: Pathophysiology of Their Disorders
Rad NK; Heydari Z; Tamimi AH; Zahmatkesh E; Shpichka A; Barekat M; Timashev P; Hossein-khannazer N; Hassan M; Vosough M
Review: FRONTIERS IN ONCOLOGY. 2024;14:1377761
P53/NANOG balance; the leading switch between poorly to well differentiated status in liver cancer cells
Ranjbar-Niavol F; Rezaei N; Zhao Y; Mirzaei H; Hassan M; Vosough M
Editorial comment: CELL JOURNAL. 2023;25(10):738-740
A Shadow of Knowledge in Stem Cell Science
Omid-Shafiei S; Hassan M; Nussler AK; Najimi M; Vosough M
Review: CELLS. 2023;12(18):2260
Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma
Salehi M; Lavasani ZM; Alikhani HK; Shokouhian B; Hassan M; Najimi M; Vosough M
Review: CELL JOURNAL. 2023;25(5):281-290
Platelet-Rich Plasma in Regenerative Medicine: Possible Applications in Management of Burns and Post-Burn Scars: A Review
Hosseini MS; Nouri M; Zarrabi M; Fatemi MJ; Shpichka A; Timashev P; Hassan M; Vosough M
Review: BIOMEDICINE & PHARMACOTHERAPY. 2023;161:114487
Autophagy orchestrates resistance in hepatocellular carcinoma cells
Seydi H; Nouri K; Rezaei N; Tamimi A; Hassan M; Mirzaei H; Vosough M
Review: BIOMEDICAL MATERIALS. 2023;18(3):032001
Progress and promise of cell sheet assisted cardiac tissue engineering in regenerative medicine
Abdolahzadeh H; Rad NK; Shpichka A; Golroo R; Rahi K; Timashev P; Hassan M; Vosough M
Review: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023;17(3):237-249
Cell and cell-derivative-based therapy for liver diseases: current approaches and future promises
Zahmatkesh E; Rad NK; Hossein-Khannazer N; Mohamadnejad M; Gramignoli R; Najimi M; Malekzadeh R; Hassan M; Vosough M
Review: JOURNAL OF CELLULAR PHYSIOLOGY. 2022;237(11):3984-4000
Hepatogenesis and hepatocarcinogenesis: Alignment of the main signaling pathways
Shokouhian B; Es HA; Negahdari B; Tamimi A; Shahdoust M; Shpichka A; Timashev P; Hassan M; Vosough M
Review: JOURNAL OF PERSONALIZED MEDICINE. 2022;12(11):1797
Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients
Zhao Y; He R; Oerther S; Zhou W; Vosough M; Hassan M
Review: MOLECULAR BIOLOGY REPORTS. 2022;49(2):1545-1549
Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients
Shahriari-Felordi M; Alikhani HK; Hashemian S-MR; Hassan M; Vosough M
Editorial comment: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2022;16(1):1-3
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?
Shahrbaf MA; Hassan M; Vosough M
Review: FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 2022;10:894800
Regulatory Non-Coding RNAs in Familial Hypercholesterolemia, Theranostic Applications
Alikhani HK; Pourhamzeh M; Seydi H; Shokoohian B; Hossein-khannazer N; Jamshidi-adegani F; Al-Hashmi S; Hassan M; Vosough M
Review: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2021;25(18):8602-8614
Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
Shokoohian B; Negahdari B; Es HA; Abedi-Valugerdi M; Baghaei K; Agarwal T; Maiti TK; Hassan M; Najimi M; Vosough M
Review: PHARMACOLOGY & THERAPEUTICS. 2021;220:107714
Novel molecular targets in gastric adenocarcinoma
Ramezankhani R; Solhi R; Es HA; Vosough M; Hassan M
Review: ACS NANO. 2021;15(3):3754-3807
X-ray-Based Techniques to Study the Nano-Bio Interface
Sanchez-Cano C; Alvarez-Puebla RA; Abendroth JM; Beck T; Blick R; Cao Y; Caruso F; Chakraborty I; Chapman HN; Chen C; Cohen BE; Conceicao ALC; Cormode DP; Cui D; Dawson KA; Falkenberg G; Fan C; Feliu N; Gao M; Gargioni E; Glueer C-C; Gruener F; Hassan M; Hu Y; Huang Y; Huber S; Huse N; Kang Y; Khademhosseini A; Keller TF; Koernig C; Kotov NA; Koziej D; Liang X-J; Liu B; Liu S; Liu Y; Liu Z; Liz-Marzan LM; Ma X; Machicote A; Maison W; Mancuso AP; Megahed S; Nickel B; Otto F; Palencia C; Pascarelli S; Pearson A; Penate-Medina O; Qi B; Raedler J; Richardson JJ; Rosenhahn A; Rothkamm K; Rubhausen M; Sanyal MK; Schaak RE; Schlemmer H-P; Schmidt M; Schmutzler O; Schotten T; Schulz F; Sood AK; Spiers KM; Staufer T; Stemer DM; Stierle A; Sun X; Tsakanova G; Weiss PS; Weller H; Westermeier F; Xu M; Yan H; Zeng Y; Zhao Y; Zhao Y; Zhu D; Zhu Y; Parak WJ
Review: FRONTIERS IN MICROBIOLOGY. 2021;12:785856
Application of Stem Cell-Derived Extracellular Vesicles as an Innovative Theranostics in Microbial Diseases
Alikhani HK; Shokoohian B; Rezasoltani S; Hossein-Khannazer N; Yadegar A; Hassan M; Vosough M
Editorial comment: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(9):e235-e236
Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al ''Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement''
Dupuis LL; Quinones CM; Ritchie J; Carpenter PA; Bauters T; Yeh RF; Anasetti C; Boelens JJ; Hamerschlak N; Hassan M; Kang HJ; Kanda Y; Paci A; Perales M-A; Shaw PJ; Seewaldt VL; Savani BN; Militano O; Pulsipher MA; McCune JS
Editorial comment: FRONTIERS IN NEUROANATOMY. 2016;10:14
Commentary: Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus
Sabry MA; Fares M; Folkesson R; Al-Ramadan M; Alabkal J; Al-Kafaji G; Hassan M
Editorial comment: HAEMATOLOGICA. 2014;99(7):1124-1127
Hematologic malignancies in elderly patients
Hassan M; Abedi-Valugerdi M
Review: PHARMACOGENOMICS. 2013;14(1):75-87
Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation
Hassan M; Andersson BS
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(2):S345
DYNAMICS OF DONOR T CELL ACTIVATION DURING EARLY PHASE OF GRAFT VERSUS HOST DISEASE (GVHD): DONOR ANTIGEN PRESENTING CELLS CAN ACTIVATE ALLOGENEIC T CELLS
Sadeghi B; Al-Hashmi S; Hassan Z; Hassan M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):127
N-ACETYL-L-CYSTEINE PROMOTES T CELL MEDIATED IMMUNITY IN ALLOGENEIC SETTINGS IN VIVO AND IN VITRO
Karlsson H; Nava S; Remberger M; Hassan Z; Hassan M; Ringden O
Meeting abstract: LEUKEMIA RESEARCH. 2007;31:S62-S63
Hypomethylation and apoptosis in 5-azacytidine treated myeloid cells
Khan R; Schmidt-Mende J; Karimi M; Forsblom A-M; Gogvadze V; Hassan M; Ekstrom TJ; Zhivotovsky B; Hellstrom-Lindberg E
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):70-71
The role of human CYP2B6 polymorphism in the bioactivation of cyclophosphamide using CDNA expressed enzymes
Afsharian P; Teredius Y; Hidestrand M; Ingelman-Sundberg M; Hassan M; Lundgren S
Meeting abstract: BLOOD. 2006;108(11):97A
Effect of busulphan dose adjustment on regimen-related toxicity.
Hassan Z; Remberger M; Ringden O; Oberg G; Bekassy AN; Hassan M
Meeting abstract: BLOOD. 2005;106(11):193B
The effect of repeated administration of cyclophosphamide on CYP2B1 and 2B2 in rat.
Afsharian P; Terelius Y; Lundgren S; Hassan M
Meeting abstract: BLOOD. 2005;106(11):60A
Long-term follow-up of patients treated by gene therapy for X-linked chronic granulomatous disease.
Ott MG; Grez M; Stein S; Siler U; Koehl U; Kuehlcke K; Schmidt M; Schilz A; Kunkel H; Naundorf S; Brinkmann A; Hassan M; von Kalle C; Trasher A; Seger R; Hoelzer D
Published conference paper: PEDIATRIC BLOOD & CANCER. 2001;36(1):127-131
The vitamin A analogues:: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo
Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CPF; Kogner P
Review: MEDICAL ONCOLOGY. 1999;16(3):166-176
The role of busulfan in bone marrow transplantation
Hassan M
Published conference paper: PEDIATRIC RESEARCH. 1999;46(3):328-332
The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo
Borgström P; Hassan M; Wassberg E; Refai E; Jonsson C; Larsson SA; Jacobsson H; Kogner P
Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2084-2089
Somatostatin in neuroblastoma and ganglioneuroma
Kogner P; Borgström P; Bjellerup P; Schilling FH; Refai E; Jonsson C; Dominici C; Wassberg E; Bihl H; Jacobsson H; Theodorsson E; Hassan M
Review: LEUKEMIA & LYMPHOMA. 1996;22(5-6):395-407
Aspects concerning busulfan pharmacokinetics and bioavailability
Hassan M; Ehrsson H; Ljungman P
Visa fler

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI